4//SEC Filing
Muller Lorenz 4
Accession 0001209191-20-035110
CIK 0001408443other
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 6:59 PM ET
Size
17.5 KB
Accession
0001209191-20-035110
Insider Transaction Report
Form 4
Muller Lorenz
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Shares
2020-04-03$1.54/sh+18,043$27,786→ 102,686 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-04-03−32,528→ 55,454 totalExercise: $1.54Exp: 2027-10-11→ Common Shares (32,528 underlying) - Award
Employee Stock Option (right to buy)
2020-06-05+35,000→ 35,000 totalExercise: $3.74Exp: 2030-06-05→ Common Shares (35,000 underlying) - Exercise/Conversion
Common Shares
2019-10-01$1.54/sh+2,500$3,850→ 52,115 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-10-01−2,500→ 87,982 totalExercise: $1.54Exp: 2027-10-11→ Common Shares (2,500 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2020-04-03−18,043→ 32,903 totalExercise: $1.54Exp: 2028-10-15→ Common Shares (18,043 underlying) - Exercise/Conversion
Common Shares
2020-04-03$1.54/sh+32,528$50,093→ 84,643 total
Footnotes (3)
- [F1]The original grant was for 140,100 option shares. Twenty-five percent (25%) of the shares subject to the option vested on October 11, 2018, and one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F2]The original grant was for 50,946 option shares. Twenty-five percent (25%) of the shares subject to the option shall vest on October 15, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F3]The shares subject to this option shall vest in twenty-four (24) equal monthly installments commencing on July 5, 2020, subject to the recipient continuing to provide service to the Issuer through each such date.
Documents
Issuer
Milestone Pharmaceuticals Inc.
CIK 0001408443
Entity typeother
Related Parties
1- filerCIK 0001771207
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 6:59 PM ET
- Size
- 17.5 KB